Market Tracker

12/08 11:00am ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.21
BATS BZX Real-Time Price
As of 10:57am ET
 +0.10 / +2.43%
Today’s Change
3.78
Today|||52-Week Range
10.95
-60.98%
Year-to-Date

Today’s Trading

Previous close4.11
Today’s open4.13
Day’s range4.06 - 4.22
Volume31,896
Average volume (3 months)1,872,486
Market cap$597.3M
Dividend yield--
Data as of 10:57am ET, 12/08/2016

Growth & Valuation

Earnings growth (last year)+94.29%
Earnings growth (this year)-1,408.61%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)--
P/E ratioNM
Price/Sales20.49
Price/Book1.33

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...0.000.00%
FLXNFlexion Therapeutics...+0.19+1.00%
CLLSCellectis SA-0.21-1.20%
GBTGlobal Blood Therape...+0.25+1.57%
Data as of 10:59am ET, 12/08/2016

Financials

Next reporting dateMarch 9, 2017
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$66.1M
Annual profit (last year)-$5.0M
Net profit margin-7.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Executive VP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts